Claritin RediTabs 10 mg 24HR Disintegrating Oral Tablet
RxNorm 744830
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 744830 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Claritin RediTabs 10 mg 24HR Disintegrating Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Claritin 10 mg Disintegrating Oral Tablet
(Atom ID: 6355835)
SYPrescribable
Synonym (SY):
Claritin 24HR RediTabs 10 mg Disintegrating Oral Tablet
(Atom ID: 6355834)
PSNPrescribable
Prescribable Name (PSN):
Claritin RediTabs 10 mg 24HR Disintegrating Oral Tablet
(Atom ID: 8215993)
SBDPrescribable
Semantic Branded Drug (SBD):
Loratadine 10 mg Disintegrating Oral Tablet [Claritin]
(Atom ID: 12370460)
Patient Education
Loratadine
Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and other allergies. These symptoms include sneezing, runny nose, and itchy eyes, nose, or throat. Loratadine is also used to treat itching and redness caused by hives. However, loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of loratadine alone. If you are taking the loratadine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.